United States (US) mRNA Vaccine Market (2025-2031) | Companies, Value, Outlook, Growth, Analysis, Size & Revenue, Competitive Landscape, Trends, Industry, Forecast, Share, Segmentation

Market Forecast By Application (COVID-19, Others), By End users (Government, Private Hospitals & Clinics, Others) And Competitive Landscape
Product Code: ETC9979912 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Dhaval Chaurasia No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) mRNA Vaccine Market Outlook
  • Market Size of United States (US) mRNA Vaccine Market, 2024
  • Forecast of United States (US) mRNA Vaccine Market, 2031
  • Historical Data and Forecast of United States (US) mRNA Vaccine Revenues & Volume for the Period 2021- 2031
  • United States (US) mRNA Vaccine Market Trend Evolution
  • United States (US) mRNA Vaccine Market Drivers and Challenges
  • United States (US) mRNA Vaccine Price Trends
  • United States (US) mRNA Vaccine Porter's Five Forces
  • United States (US) mRNA Vaccine Industry Life Cycle
  • Historical Data and Forecast of United States (US) mRNA Vaccine Market Revenues & Volume By Application for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) mRNA Vaccine Market Revenues & Volume By COVID-19 for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) mRNA Vaccine Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) mRNA Vaccine Market Revenues & Volume By End users for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) mRNA Vaccine Market Revenues & Volume By Government for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) mRNA Vaccine Market Revenues & Volume By Private Hospitals & Clinics for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) mRNA Vaccine Market Revenues & Volume By Others for the Period 2021- 2031
  • United States (US) mRNA Vaccine Import Export Trade Statistics
  • Market Opportunity Assessment By Application
  • Market Opportunity Assessment By End users
  • United States (US) mRNA Vaccine Top Companies Market Share
  • United States (US) mRNA Vaccine Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) mRNA Vaccine Company Profiles
  • United States (US) mRNA Vaccine Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United States (US) mRNA Vaccine Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) mRNA Vaccine Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) mRNA Vaccine Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) mRNA Vaccine Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) mRNA Vaccine Market - Industry Life Cycle

3.4 United States (US) mRNA Vaccine Market - Porter's Five Forces

3.5 United States (US) mRNA Vaccine Market Revenues & Volume Share, By Application, 2021 & 2031F

3.6 United States (US) mRNA Vaccine Market Revenues & Volume Share, By End users, 2021 & 2031F

4 United States (US) mRNA Vaccine Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness about the benefits of mRNA vaccines for infectious diseases

4.2.2 Growing investment in research and development of mRNA vaccine technology

4.2.3 Favorable regulatory environment for the approval and distribution of mRNA vaccines in the US

4.3 Market Restraints

4.3.1 Potential safety concerns and side effects associated with mRNA vaccines

4.3.2 Supply chain constraints and logistical challenges in manufacturing and distribution

4.3.3 Competition from traditional vaccines and other new vaccine technologies

5 United States (US) mRNA Vaccine Market Trends

6 United States (US) mRNA Vaccine Market, By Types

6.1 United States (US) mRNA Vaccine Market, By Application

6.1.1 Overview and Analysis

6.1.2 United States (US) mRNA Vaccine Market Revenues & Volume, By Application, 2021- 2031F

6.1.3 United States (US) mRNA Vaccine Market Revenues & Volume, By COVID-19, 2021- 2031F

6.1.4 United States (US) mRNA Vaccine Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) mRNA Vaccine Market, By End users

6.2.1 Overview and Analysis

6.2.2 United States (US) mRNA Vaccine Market Revenues & Volume, By Government, 2021- 2031F

6.2.3 United States (US) mRNA Vaccine Market Revenues & Volume, By Private Hospitals & Clinics, 2021- 2031F

6.2.4 United States (US) mRNA Vaccine Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) mRNA Vaccine Market Import-Export Trade Statistics

7.1 United States (US) mRNA Vaccine Market Export to Major Countries

7.2 United States (US) mRNA Vaccine Market Imports from Major Countries

8 United States (US) mRNA Vaccine Market Key Performance Indicators

8.1 Vaccine efficacy rate in clinical trials

8.2 Rate of vaccine adoption among targeted population groups

8.3 Investment in mRNA vaccine research and development

8.4 Number of partnerships and collaborations between pharmaceutical companies and research institutions for mRNA vaccine development

8.5 Regulatory approvals for new mRNA vaccines and expansion of indications

9 United States (US) mRNA Vaccine Market - Opportunity Assessment

9.1 United States (US) mRNA Vaccine Market Opportunity Assessment, By Application, 2021 & 2031F

9.2 United States (US) mRNA Vaccine Market Opportunity Assessment, By End users, 2021 & 2031F

10 United States (US) mRNA Vaccine Market - Competitive Landscape

10.1 United States (US) mRNA Vaccine Market Revenue Share, By Companies, 2024

10.2 United States (US) mRNA Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Related Reports

Industry Events and Analyst Meet

Whitepaper

Read All